(Q40586745)

English

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

scientific article published on November 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

phase I clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Reid T

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Galanis E

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Abbruzzese J

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sze D

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Andrews J

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Romel L

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hatfield M

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rubin J

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kirn D

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1618-1626

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gene therapy: adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Replication-selective microbiological agents: fighting cancer with targeted germ warfare

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Replication-selective adenoviruses as oncolytic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Gene therapy death prompts review of adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Gene therapy death--"everyone has to share in the guilt".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Gene therapy on trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301512

21 January 2018

Gene therapy setback.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urea cycle disorders: diagnosis, pathophysiology, and therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ONYX-015: clinical data are encouraging

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/11895000

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.GT.3301512

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40586745&oldid=2203808401"